Gene · 84464
Papers1,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation. | Sci Adv | 2025 | 40367183 | PubTator, text mining | PubMed |
| USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer. | Cell Death Dis | 2025 | 40240356 | PubTator, text mining | PubMed |
| Biochemical Mechanisms of Genetic Recombination and DNA Repair. | Annu Rev Biochem | 2025 | 40153609 | PubTator, text mining | PubMed |
| SLX4 and XPF are involved in cell migration and EMT in a cell-specific manner. | Biochem Pharmacol | 2025 | 40118290 | PubTator, text mining | PubMed |
| Case Report: A Novel Homozygous Variant in the SLX4 Gene Causes Fanconi Anemia. | Genet Test Mol Biomarkers | 2025 | 39841989 | PubTator, text mining | PubMed |
| Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage. | Nat Cell Biol | 2025 | 39805921 | PubTator, text mining | PubMed |
| Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. | Eur Urol Open Sci | 2025 | 39717660 | PubTator, text mining | PubMed |
| PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells. | Oncogene | 2025 | 39695328 | PubTator, text mining | PubMed |
| Recent Advances in Mass Spectrometry-Based Protein Interactome Studies. | Mol Cell Proteomics | 2025 | 39608603 | PubTator, text mining | PubMed |
| 2D Cerium-Organic Frameworks as an Efficient Heterogeneous Catalyst for the Synthesis of 1,4-Dihydropyridines via Hantzsch Reaction. | Chem Asian J | 2025 | 39575600 | PubTator, text mining | PubMed |
| Germline variants of homology-directed repair or mismatch repair genes in cervical cancer. | Int J Cancer | 2025 | 39440754 | PubTator, text mining | PubMed |
| Comparative sequencing study of mismatch repair and homology-directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan. | Int J Cancer | 2025 | 39400928 | PubTator, text mining | PubMed |
| Ultrarare Variants in DNA Damage Repair Genes in Pediatric Acute-Onset Neuropsychiatric Syndrome or Acute Behavioral Regression in Neurodevelopmental Disorders. | Dev Neurosci | 2025 | 39396515 | PubTator, text mining | PubMed |
| Presence of RB1 or Absence of LRP1B Mutation Predicts Poor Overall Survival in Patients with Gastric Neuroendocrine Carcinoma and Mixed Adenoneuroendocrine Carcinoma. | Cancer Res Treat | 2025 | 39327909 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers. | Front Cell Infect Microbiol | 2024 | 39926115 | PubTator, text mining | PubMed |
| Microdissection of Distinct Morphological Regions Within Uveal Melanomas Identifies Novel Drug Targets. | Cancers (Basel) | 2024 | 39766052 | PubTator, text mining | PubMed |
| Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors. | Front Med (Lausanne) | 2024 | 39421870 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
| Multifaceted roles of SUMO in DNA metabolism. | Nucleus | 2024 | 39287196 | PubTator, text mining | PubMed |
| [Biological characteristics of triple negative breast cancer with low expression of HER2]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39231741 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84464/papers?page=4